ROMO1 is a 79-amino acid mitochondrial inner membrane protein that regulates reactive oxygen species (ROS) production and modulates oxidative stress pathways . Recombinant versions are produced in heterologous systems like E. coli, yeast, and baculovirus for studies in oxidative stress, antibacterial activity, and mitochondrial dynamics .
ROS Modulation: Induces ROS production via mitochondrial electron transport chain interactions, critical for cellular proliferation and stress responses .
Antibacterial Activity: Disrupts bacterial membranes (e.g., S. aureus, P. aeruginosa) through membrane permeabilization .
Mitochondrial Dynamics: Interacts with translocases (e.g., TIM16, TIM23) to regulate protein import and inner membrane integrity .
COVID-19 Cytokine Storm: Recombinant Spike protein (rSpike) upregulated romo1 mRNA, correlating with oxidative stress and inflammation. Photobiomodulation (PBM) reduced romo1 expression, suggesting therapeutic potential .
Mitochondrial Interactions: ROMO1 partners with TIM16 (score: 0.897) and TIM23 (score: 0.832) in mitochondrial protein import .
Recombinant Form | Expression System | Applications | Purity |
---|---|---|---|
RFL29469HF | E. coli | SDS-PAGE, functional assays | >90% |
CSB-YP020063DIL1 | Yeast | Structural studies, antibody production | Inquire |
CSB-EP020063DIL1 | E. coli | Biotinylation assays | Inquire |
Oxidative Stress Studies: Used to model ROS-mediated diseases (e.g., infertility, cancer) .
Drug Screening: Evaluates compounds targeting mitochondrial ROS pathways .
Antibacterial Development: Tests efficacy against multidrug-resistant bacteria .